These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Comparison of efficacy of immune checkpoint inhibitors (ICIs) between younger and older patients: A systematic review and meta-analysis. Nishijima TF; Muss HB; Shachar SS; Moschos SJ Cancer Treat Rev; 2016 Apr; 45():30-7. PubMed ID: 26946217 [TBL] [Abstract][Full Text] [Related]
3. Aging, immune senescence, and immunotherapy: A comprehensive review. Elias R; Hartshorn K; Rahma O; Lin N; Snyder-Cappione JE Semin Oncol; 2018 Aug; 45(4):187-200. PubMed ID: 30539714 [TBL] [Abstract][Full Text] [Related]
4. Immunosenescence and immunecheckpoint inhibitors in non-small cell lung cancer patients: Does age really matter? Ferrara R; Mezquita L; Auclin E; Chaput N; Besse B Cancer Treat Rev; 2017 Nov; 60():60-68. PubMed ID: 28889085 [TBL] [Abstract][Full Text] [Related]
5. Checkpoint Inhibitors for Non-Small Cell Lung Cancer Among Older Adults. Elias R; Morales J; Presley C Curr Oncol Rep; 2017 Sep; 19(9):62. PubMed ID: 28755314 [TBL] [Abstract][Full Text] [Related]
6. Immunosenescence and cancer. Pawelec G Biogerontology; 2017 Aug; 18(4):717-721. PubMed ID: 28220304 [TBL] [Abstract][Full Text] [Related]
7. Epigenetic modifiers in immunotherapy: a focus on checkpoint inhibitors. Terranova-Barberio M; Thomas S; Munster PN Immunotherapy; 2016 Jun; 8(6):705-19. PubMed ID: 27197539 [TBL] [Abstract][Full Text] [Related]
8. Aging, cancer, and antitumor immunity. Ikeda H; Togashi Y Int J Clin Oncol; 2022 Feb; 27(2):316-322. PubMed ID: 33783658 [TBL] [Abstract][Full Text] [Related]
9. Immune Checkpoint Inhibitors in Older Adults. Elias R; Morales J; Rehman Y; Khurshid H Curr Oncol Rep; 2016 Aug; 18(8):47. PubMed ID: 27287329 [TBL] [Abstract][Full Text] [Related]
10. Immune Checkpoint Inhibitors: The Unexplored Landscape of Geriatric Oncology. Choucair K; Naqash AR; Nebhan CA; Nipp R; Johnson DB; Saeed A Oncologist; 2022 Sep; 27(9):778-789. PubMed ID: 35781739 [TBL] [Abstract][Full Text] [Related]
11. Immune Checkpoint Inhibitor Toxicity Review for the Palliative Care Clinician. Hansen ED; Wang X; Case AA; Puzanov I; Smith T J Pain Symptom Manage; 2018 Sep; 56(3):460-472. PubMed ID: 29792979 [TBL] [Abstract][Full Text] [Related]
12. Ongoing Phase I Studies of Immune Checkpoint Inhibitors in China. Fang W; Zhao S; Zhang Y; Ma Y; Zhao H; Zhang L Oncologist; 2019 Feb; 24(Suppl 1):S11-S20. PubMed ID: 30819827 [TBL] [Abstract][Full Text] [Related]
13. Cancer Immunotherapy in Older Patients. Marrone KA; Forde PM Cancer J; 2017; 23(4):219-222. PubMed ID: 28731944 [TBL] [Abstract][Full Text] [Related]
14. Management of immunotherapy toxicities in older adults. Bhandari S; Gill AS; Perez CA; Jain D Semin Oncol; 2018 Aug; 45(4):226-231. PubMed ID: 30446167 [TBL] [Abstract][Full Text] [Related]
15. Considerations for successful cancer immunotherapy in aged hosts. Hurez V; Padrón ÁS; Svatek RS; Curiel TJ Clin Exp Immunol; 2017 Jan; 187(1):53-63. PubMed ID: 27690272 [TBL] [Abstract][Full Text] [Related]
16. Immune Aging and Immunotherapy in Cancer. Kaiser M; Semeraro MD; Herrmann M; Absenger G; Gerger A; Renner W Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34209842 [TBL] [Abstract][Full Text] [Related]
17. Checkpoint inhibitors in immunotherapy of ovarian cancer. Wang DH; Guo L; Wu XH Tumour Biol; 2015 Jan; 36(1):33-9. PubMed ID: 25409618 [TBL] [Abstract][Full Text] [Related]
19. Update on New Therapies With Immune Checkpoint Inhibitors. Peterson JJ; Steele-Moses SK Clin J Oncol Nurs; 2016 Aug; 20(4):405-10. PubMed ID: 27441513 [TBL] [Abstract][Full Text] [Related]
20. Immune checkpoint inhibitors for Indian patients: A note of caution. Venniyoor A Indian J Cancer; 2016; 53(3):468-469. PubMed ID: 28244488 [No Abstract] [Full Text] [Related] [Next] [New Search]